MARIA CHRISTINA ERRAZO: Open Payments
NPI 1932644812 · EAST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 109 payments from 17 companies in 2025. Trend: 2023 $1,221 · 2024 $967 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $334 |
| Lilly USA, LLC | 13 | $227 |
| Amgen Inc. | 11 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $165 |
| ABBVIE INC. | 12 | $160 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| PFIZER INC. | 7 | $113 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Insulet Corporation | 3 | $62 |
Products named: Ozempic, XIFAXAN, MOUNJARO, JARDIANCE, OTEZLA, UBRELVY, TRELEGY ELLIPTA, LEQVIO.
Industry payments across NJ — which companies pay providers there.
